IBNAX
Price
$24.02
Change
+$0.15 (+0.63%)
Updated
Jan 17 closing price
Net Assets
1.54B
RLBEX
Price
$34.94
Change
+$0.22 (+0.63%)
Updated
Jan 17 closing price
Net Assets
238.66B
Ad is loading...

IBNAX vs RLBEX

Header iconIBNAX vs RLBEX Comparison
Open Charts IBNAX vs RLBEXBanner chart's image
Macquarie Balanced Fund
Price$24.02
Change+$0.15 (+0.63%)
VolumeN/A
Net Assets1.54B
American Funds American Balanced R4
Price$34.94
Change+$0.22 (+0.63%)
VolumeN/A
Net Assets238.66B
IBNAX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IBNAX vs. RLBEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNAX is a Hold and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 239B vs. IBNAX (1.54B). RLBEX pays higher dividends than IBNAX: RLBEX (2.24) vs IBNAX (2.06). IBNAX was incepted earlier than RLBEX: IBNAX (37 years) vs RLBEX (23 years). RLBEX is a more actively managed with annual turnover of: 171.00 vs. IBNAX (82.00). RLBEX has a lower initial minimum investment than IBNAX: RLBEX (250) vs IBNAX (1000). IBNAX annual gain was more profitable for investors over the last year : 18.51 vs. RLBEX (12.28). RLBEX return over 5 years is better than : 29.82 vs. IBNAX (1.40).
IBNAXRLBEXIBNAX / RLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years23 years-
Gain YTD1.9521.955100%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.54B239B1%
Annual Yield % from dividends2.062.2492%
Returns for 1 year18.5112.28151%
Returns for 3 years-3.7112.34-30%
Returns for 5 years1.4029.825%
Returns for 10 years6.3858.0411%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSS13.000.15
+1.17%
Kohls Corp
GGB2.830.01
+0.35%
Gerdau SA
EW69.78-0.08
-0.11%
Edwards Lifesciences Corp
CTSO1.03-0.01
-0.96%
Cytosorbents Corp
GLUE5.66-0.11
-1.82%
Monte Rosa Therapeutics